Mee Wah Loo
Adult Health · New York, NYNPI 1861738866
Payments from drug & device makers
Across 138 payments — averaging $30.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Acadia Pharmaceuticals Inc$569
- Lundbeck LLC$475
- Amneal Pharmaceuticals LLC$400
- Axsome Therapeutics, Inc.$389
- Otsuka Pharmaceutical Development & Commercialization, Inc.$245
- plus $1K from 11 others
What the payments were for
- Speaking & faculty fees$190%
- Food & beverage$4,140100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $1,057 |
| Acadia Pharmaceuticals Inc | 18 | $569 |
| Lundbeck LLC | 24 | $475 |
| Amneal Pharmaceuticals LLC | 3 | $400 |
| Axsome Therapeutics, Inc. | 7 | $389 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $245 |
| UCB, Inc. | 9 | $226 |
| Otsuka America Pharmaceutical, Inc. | 10 | $209 |
| Idorsia Pharmaceuticals US Inc | 4 | $170 |
| Pfizer | 7 | $152 |
| Lilly USA, LLC | 5 | $104 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Argenx US, Inc. | 2 | $40 |
| AstraZeneca | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| MDD US Operations, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,159 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 21 | $103,458 |
| NamzaricMemantine Hcl/Donepezil Hcl | 49 | $35,011 |
| QuliptaAtogepant | 30 | $32,512 |
| UbrelvyUbrogepant | 21 | $28,417 |
| RexultiBrexpiprazole | 18 | $26,874 |
| Nurtec OdtRimegepant Sulfate | 15 | $22,549 |
| Diclofenac Epolamine | 15 | $9,882 |
| QuviviqDaridorexant Hcl | 17 | $8,325 |
| VascepaIcosapent Ethyl | 20 | $6,808 |
| Rivastigmine | 46 | $4,035 |
| RivastigmineRivastigmine Tartrate | 93 | $2,779 |
| Rasagiline Mesylate | 15 | $2,637 |
| Entacapone | 29 | $2,496 |
| Lidocaine | 21 | $2,223 |
| Diclofenac Sodium | 11 | $2,170 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $569 | $103,45821 claims |
| AbbVieNamzaric, Qulipta, Ubrelvy | $1,057 | $95,940100 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $209 | $26,87418 claims |
| PfizerNurtec Odt | $152 | $22,54915 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $170 | $8,32517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.